Loading...
XWARNEU
Market cap965mUSD
Dec 20, Last price  
877.00PLN
1D
-1.90%
1Q
8.27%
Jan 2017
124.87%
Name

Neuca SA

Chart & Performance

D1W1MN
XWAR:NEU chart
P/E
26.94
P/S
0.33
EPS
32.55
Div Yield, %
1.48%
Shrs. gr., 5y
-2.38%
Rev. gr., 5y
8.79%
Revenues
11.81b
+5.16%
1,414,766,0001,700,854,0003,288,786,0003,969,629,0005,687,344,0006,131,679,0006,388,658,0005,687,431,0005,795,092,0006,568,700,0006,945,703,0007,077,194,0007,485,234,0007,753,263,0008,278,727,0009,254,014,0009,864,258,00011,232,540,00011,812,636,000
Net income
146m
+6.58%
10,810,00011,275,00016,350,00014,104,00036,336,00037,563,00053,192,00066,016,00085,347,00093,070,000101,284,000111,727,00094,497,00098,274,000117,655,000141,791,000150,655,000137,238,000146,269,000
CFO
288m
-14.19%
13,200,000-11,013,00084,072,00035,614,00048,994,00014,111,000166,079,000124,920,00027,696,000202,556,000180,402,000175,049,000121,764,000121,935,000202,247,000324,671,000300,198,000335,937,000288,271,000
Dividend
Jun 12, 202414.5 PLN/sh
Earnings
Mar 26, 2025

Profile

NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
URL
https://www.neuca.pl/
IPO date
Sep 30, 2004
Employees
3,981
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
11,812,636
5.16%
11,232,540
13.87%
9,864,258
6.59%
Cost of revenue
11,560,963
11,006,265
9,614,254
Unusual Expense (Income)
NOPBT
251,673
226,275
250,004
NOPBT Margin
2.13%
2.01%
2.53%
Operating Taxes
44,330
54,359
49,683
Tax Rate
17.61%
24.02%
19.87%
NOPAT
207,343
171,916
200,321
Net income
146,269
6.58%
137,238
-8.91%
150,655
6.25%
Dividends
(58,229)
(51,565)
(44,166)
Dividend yield
1.40%
1.73%
1.13%
Proceeds from repurchase of equity
2,922
(55,964)
(36,549)
BB yield
-0.07%
1.88%
0.94%
Debt
Debt current
383,928
229,966
44,025
Long-term debt
461,153
323,736
284,543
Deferred revenue
106,615
Other long-term liabilities
72,599
188,248
139,606
Net debt
623,357
267,105
160,248
Cash flow
Cash from operating activities
288,271
335,937
300,198
CAPEX
(94,183)
(81,448)
(52,751)
Cash from investing activities
(257,027)
(180,219)
(145,485)
Cash from financing activities
(139,093)
(6,636)
(112,758)
FCF
202,153
(56,129)
361,183
Balance
Cash
119,547
225,867
89,181
Long term investments
102,177
60,730
79,139
Excess cash
Stockholders' equity
765,604
719,458
676,774
Invested Capital
1,793,233
1,489,512
1,276,134
ROIC
12.63%
12.43%
17.08%
ROCE
14.03%
15.14%
19.49%
EV
Common stock shares outstanding
4,503
4,575
4,634
Price
925.00
42.31%
650.00
-22.62%
840.00
29.03%
Market cap
4,165,606
40.07%
2,973,860
-23.59%
3,892,174
34.84%
EV
4,855,807
3,291,268
4,089,943
EBITDA
366,279
324,192
329,536
EV/EBITDA
13.26
10.15
12.41
Interest
84,342
47,733
11,470
Interest/NOPBT
33.51%
21.10%
4.59%